Biotech’s Finest Hour

The COVID-19 pandemic has changed the world in fundamental ways, and the biotechnology sector has been summoned to marshal its broad arsenal of next-generation weapons to beat this disease. As the world undergoes a change, so, too, does BIO. In a fascinating hour of dialogue, history, multimedia content and conversation, learn how the biotech sector is rising to meet the greatest public health challenge in a century from BIO Chairman Jeremy Levin, new BIO President and CEO Michelle McMurry-Heath and outgoing CEO and industry champion Jim Greenwood.